S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
Log in

Nymox Pharmaceutical SEC Filings & 10K Form (NASDAQ:NYMX)

$3.17
+0.03 (+0.96 %)
(As of 02/17/2020 04:00 PM ET)
Today's Range
$3.12
Now: $3.17
$3.50
50-Day Range
$2.20
MA: $3.08
$3.88
52-Week Range
$1.32
Now: $3.17
$4.09
Volume157,504 shs
Average Volume272,879 shs
Market Capitalization$221.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.8

SEC Filings

Nymox Pharmaceutical (NASDAQ:NYMX) SEC Filings

DateFilerForm TypeView
11/19/2019
1:55 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2019
2:36 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2019
2:41 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2019
1:07 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
9:59 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
12:59 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
10:33 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
2:13 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
2:53 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
10:14 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
10:41 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
10:55 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
11:57 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
1:27 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
11:19 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
9:53 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
9:27 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
10:42 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
10:15 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:28 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
11:11 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
9:51 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
11:19 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
11:14 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
2:07 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2019
4:20 PM
Nymox Pharmaceutical (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/03/2019
12:09 PM
Danielsen Erik (Reporting)
Nymox Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
12:05 PM
Danielsen Erik (Reporting)
Nymox Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
2:58 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
9:43 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
9:16 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
9:28 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
10:41 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2018
1:09 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
1:34 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
2:43 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
1:29 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
2:13 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2018
6:28 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2018
9:56 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
9:51 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
9:43 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
1:50 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
4:23 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
8:39 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
8:47 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
4:33 PM
Averback Paul (Reporting)
Nymox Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
4:26 PM
Averback Paul (Reporting)
Nymox Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
4:20 PM
LANHAM RANDALL J (Reporting)
Nymox Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
10:36 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2018
2:46 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
2:17 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
2:11 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2018
10:47 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
3:30 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
2:10 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
4:11 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2018
3:22 PM
Nymox Pharmaceutical (Filer)
Form 20-F/A
03/30/2018
9:42 AM
Nymox Pharmaceutical (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2018
3:10 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2018
4:55 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2018
9:49 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2018
1:05 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2018
9:39 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
3:20 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
10:00 AM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2018
4:29 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2018
2:07 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2018
2:19 PM
Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2017
6:04 PM
Nymox Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel